Issued Patents All Time
Showing 1–25 of 54 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 11578054 | Compounds useful as immunomodulators | Denis R. St. Laurent, David R. Langley, Paul Michael Scola | 2023-02-14 |
| 11414418 | Compounds useful as immunomodulators | Juliang Zhu, Paul Michael Scola | 2022-08-16 |
| 11369624 | Salts of prodrugs of piperazine and substituted piperidine antiviral agents | Yasutsugu Ueda, Timothy P. Connolly, John F. Kadow, Nicholas A. Meanwell, Tao Wang +8 more | 2022-06-28 |
| 11161837 | Benzofuran derivatives for the treatment of hepatitis C | John F. Kadow, Rajesh Onkardas Bora, Prakash Anjanappa, Kumaravel Selvakumar, Samayamunthula Venkata Satya Arun Kumar Gupta | 2021-11-02 |
| 11046675 | Substituted isoquionline derivatives as immunomudulators | Denis R. St. Laurent, Jeffrey Lee Romine, Paul Michael Scola | 2021-06-29 |
| 10882844 | Compounds useful as immunomodulators | Katharine A. Grant-Young, Li-Qiang Sun, David R. Langley, Denis R. St. Laurent, Paul Michael Scola | 2021-01-05 |
| 10745382 | Compounds useful as immunomodulators | Timothy P. Connolly, David B. Frennesson, Katharine A. Grant-Young, Piyasena Hewawasam, David R. Langley +9 more | 2020-08-18 |
| 10590105 | 1,3-dihydroxy-phenyl derivatives useful as immunomodulators | Katharine A. Grant-Young, Juliang Zhu, Mark G. Saulnier, David B. Frennesson, Zhaoxing Meng +1 more | 2020-03-17 |
| 10538555 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Michael M. Miller, Claudio Mapelli, Martin Patrick Allen, Michael S. Bowsher, Eric P. Gillis +12 more | 2020-01-21 |
| 10150747 | Compounds for the treatment of hepatitis C | John F. Kadow, Rajesh Onkardas Bora, Prakash Anjanappa, Samayamunthula Venkata Satya Arun Kumar Gupta | 2018-12-11 |
| 10144706 | Compounds useful as immunomodulators | Katharine A. Grant-Young, Juliang Zhu, Mark G. Saulnier, David B. Frennesson, David R. Langley +7 more | 2018-12-04 |
| 10143746 | Immunomodulators | Martin Patrick Allen, Eric P. Gillis, David R. Langley, Michael M. Miller, Eric Mull +4 more | 2018-12-04 |
| 9879046 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Michael M. Miller, Martin Patrick Allen, Michael S. Bowsher, Kenneth M. Boy, Eric P. Gillis +5 more | 2018-01-30 |
| 9850225 | Compounds useful as immunomodulators | Louis S. Chupak, Min Ding, Scott W. Martin, Xiaofan Zheng, Piyasena Hewawasam +5 more | 2017-12-26 |
| 9850283 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Michael M. Miller, Claudio Mapelli, Martin Patrick Allen, Michael S. Bowsher, Kenneth M. Boy +10 more | 2017-12-26 |
| 9738653 | Fused furans for the treatment of hepatitis C | Kyle J. Eastman, Kyle E. Parcella | 2017-08-22 |
| 9556162 | Compound for the treatment of hepatitis C | Katharine A. Grant-Young | 2017-01-31 |
| 9308236 | Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions | Michael M. Miller, Claudio Mapelli, Martin Patrick Allen, Michael S. Bowsher, Kenneth M. Boy +10 more | 2016-04-12 |
| 9303020 | Compounds for the treatment of hepatitis C | John F. Kadow | 2016-04-05 |
| 9096580 | Benzofuran derivatives for the treatment of hepatitis C | — | 2015-08-04 |
| 8871771 | Salts of prodrugs of piperazine and substituted piperidine antiviral agents | Yasutsugu Ueda, Timothy P. Connolly, John F. Kadow, Nicholas A. Meanwell, Tao Wang +8 more | 2014-10-28 |
| 8722688 | Compounds for the treatment of hepatitis C | Kyle E. Parcella, John A. Bender, Brett R. Beno, Katharine A. Grant-Young, Ying Han +3 more | 2014-05-13 |
| 8536338 | Compounds for the treatment of hepatitis C | Richard Pracitto, John F. Kadow, John A. Bender, Brett R. Beno, Katharine A. Grant-Young +5 more | 2013-09-17 |
| 8507683 | Compounds for the treatment of hepatitis C | John F. Kadow, Rajesh Onkardas Bora, Kumaravel Selvakumar | 2013-08-13 |
| 8501992 | Hydroxyphenyl sulfonamides as antiapoptotic bcl inhibitors | Kyoung S. Kim, Robert M. Borzilleri, Zhen-Wei Cai | 2013-08-06 |